Innovator’s Pitch Challenge

Vote for Us

Interested in Connecting? Please contact:
Matt Handel
CEO
mhandel@xpresscells.com

Message the company or request a 1:1 meeting here

ExpressCells is a genetic-engineering company that creates genetically-edited cell lines for biological researchers. Founded in 2018, we are generating revenue and have ~20 customers. We won their business using our patented plasmid technology that allows us to (1) deliver cells more quickly than older technologies, (2) knock multiple genes into the same cell, and (3) place these genes in precise locations. The result? Better experiments, saving our biotech and pharma customers both time and money. We are now raising our Series B to accelerate our revenue and income growth.

Pitch Video

Slide Deck